ME00027B - Postupak pripremanja racemskog citaloprama i/ili s- ili r-citaloprama separacijom smješe r- i s-citaloprama - Google Patents

Postupak pripremanja racemskog citaloprama i/ili s- ili r-citaloprama separacijom smješe r- i s-citaloprama

Info

Publication number
ME00027B
ME00027B MEP-2008-15A MEP200815A ME00027B ME 00027 B ME00027 B ME 00027B ME P200815 A MEP200815 A ME P200815A ME 00027 B ME00027 B ME 00027B
Authority
ME
Montenegro
Prior art keywords
citalopram
optionally
acid addition
precipitate
crystalline
Prior art date
Application number
MEP-2008-15A
Other languages
English (en)
French (fr)
Inventor
Hans Petersen
Ole Nielsen
Rikke Eva Humble
Troels Volsgaard Christensen
Michael Harold Rock
Robert Dancer
Original Assignee
H Lundbeck As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck As filed Critical H Lundbeck As
Publication of ME00027B publication Critical patent/ME00027B/me

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Abstract

Pronalazak se odnosi na postupak za pripremanje recemske citalopram slobodne baze ili od toga nastale kisele adicione soli i/ili R- i S-citaloprama kao slobodne baze ili od toga nastale kisele adicione soli separacijom smeše R- i S-citaloprama sa više od 50% jednog od enantiomera u frakciju koja sadrži racemski citalopram i/ili frakciju S-citaloprama ili R-citaloprama naznačen time što i) se citalopram istaloži iz rastvarača kao slobodna baza ili od toga kisela adiciona so; ii) se formirani talog odvaja iz matične tečnosti; iia) ako je talog kristalan opciono se rekristališe jednom ili više puta da se formira racemski citalopram, i onda se opciono pretvara u od toga nastalu kiselu adicionu so; iib) ako talog nije kristalan, koraci i) i II) se opciono ponavljaju sve dok se ne dobije kristalni talog i kristalni talog se opciono jednom ili više puta rekristališe da formira racemski citalopram, i onda se opciono pretvara u od toga nasalu kiselu adicionu so; iii) se matična tečnost opciono podvrgava daljem prečišćavanju i S-citalopram ili R-citalopram izoluju iz matične tečnosti i opciono pretvaraju u od toga na adicionu so. Pronalazak se odnosi na postupak za pripremanje recemske citalopram slobodne baze ili od toga nastale kisele adicione soli i/ili R- i S-citaloprama kao slobodne baze ili od toga nastale kisele adicione soli separacijom smeše R- i S-citaloprama sa više od 50% jednog od enantiomera u frakciju koja sadrži racemski citalopram i/ili frakciju S-citaloprama ili R-citaloprama naznačen time što i) se citalopram istaloži iz rastvarača kao slobodna baza ili od toga kisela adiciona so; ii) se formirani talog odvaja iz matične tečnosti; iia) ako je talog kristalan opciono se rekristališe jednom ili više puta da se formira racemski citalopram, i onda se opciono pretvara u od toga nastalu kiselu adicionu so; iib) ako talog nije kristalan, koraci i) i II) se opciono ponavljaju sve dok se ne dobije kristalni talog i kristalni talog se opciono jednom ili više puta rekristališe da formira racemski citalopram, i onda se opciono pretvara u od toga nasalu kiselu adicionu so; iii) se matična tečnost opciono podvrgava daljem prečišćavanju i S-citalopram ili R-citalopram izoluju iz matične tečnosti i opciono pretvaraju u od toga na adicionu so.
MEP-2008-15A 2001-06-25 2002-06-25 Postupak pripremanja racemskog citaloprama i/ili s- ili r-citaloprama separacijom smješe r- i s-citaloprama ME00027B (me)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200100991 2001-06-25
PCT/DK2002/000426 WO2003000672A1 (en) 2001-06-25 2002-06-25 Process for the preparation of racemic citalopram and/or s- or r-citalopram by separation of a mixture of r- and s-citalopram

Publications (1)

Publication Number Publication Date
ME00027B true ME00027B (me) 2010-02-10

Family

ID=8160584

Family Applications (2)

Application Number Title Priority Date Filing Date
MEP-15/08A MEP1508A (xx) 2001-06-25 2002-06-25 Postupak pripremanja racemskog citaloprama i/ili s-ili r-citaloprama separacijom smješe r- i s- citaloprama
MEP-2008-15A ME00027B (me) 2001-06-25 2002-06-25 Postupak pripremanja racemskog citaloprama i/ili s- ili r-citaloprama separacijom smješe r- i s-citaloprama

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MEP-15/08A MEP1508A (xx) 2001-06-25 2002-06-25 Postupak pripremanja racemskog citaloprama i/ili s-ili r-citaloprama separacijom smješe r- i s- citaloprama

Country Status (40)

Country Link
US (1) US7112686B2 (me)
EP (1) EP1412341B1 (me)
JP (2) JP4377219B2 (me)
KR (4) KR20100052550A (me)
CN (2) CN100429208C (me)
AR (2) AR034612A1 (me)
AT (1) ATE284395T1 (me)
BG (1) BG66372B1 (me)
BR (1) BRPI0210574B8 (me)
CA (2) CA2450890C (me)
CO (1) CO5550420A2 (me)
CZ (1) CZ305034B6 (me)
DE (1) DE60202216T2 (me)
DK (1) DK1412341T3 (me)
EA (1) EA006446B1 (me)
ES (1) ES2233834T3 (me)
HK (2) HK1068627A1 (me)
HR (1) HRP20031075B1 (me)
HU (1) HU228476B1 (me)
IL (1) IL159229A0 (me)
IS (1) IS2426B (me)
JO (1) JO2389B1 (me)
MA (1) MA26260A1 (me)
ME (2) MEP1508A (me)
MX (1) MXPA03011770A (me)
MY (1) MY133471A (me)
NO (2) NO329873B1 (me)
NZ (1) NZ530104A (me)
PE (1) PE20030122A1 (me)
PL (1) PL366560A1 (me)
PT (1) PT1412341E (me)
RS (1) RS50673B (me)
SI (1) SI1412341T1 (me)
SK (1) SK287696B6 (me)
TN (1) TNSN02062A1 (me)
TW (1) TWI236473B (me)
UA (1) UA75147C2 (me)
UY (2) UY27356A1 (me)
WO (1) WO2003000672A1 (me)
ZA (1) ZA200309633B (me)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20040991A1 (es) 2002-08-12 2004-12-27 Lundbeck & Co As H Separacion de intermediarios para la preparacion de escitalopram
AU2003291960B2 (en) * 2002-12-23 2009-11-19 H. Lundbeck A/S A process for the preparation of racemic citalopram diol and/or S- or R- citalopram diols and the use of such diols for the preparation of racemic citalopram, R-citalopram and/or S-citalopram
PT1578738E (pt) 2002-12-23 2008-04-11 Lundbeck & Co As H Bromidrato de escitalopram e um método para a sua preparação
TWI331605B (en) * 2002-12-23 2010-10-11 Lundbeck & Co As H A process for the preparation of racemic citalopram diol and/or s- or r-citalopram diols and the use of such diols for the preparation of racemic citalopram, r-citalopram and/or s-citalopram
AU2003223105A1 (en) * 2003-03-24 2004-10-18 Hetero Drugs Limited Novel crystalline forms of (s)-citalopram oxalate
CN100569765C (zh) 2003-12-19 2009-12-16 杭州民生药业集团有限公司 西酞普兰中间体晶体碱
TWI339651B (en) * 2004-02-12 2011-04-01 Lundbeck & Co As H Method for the separation of intermediates which may be used for the preparation of escitalopram
WO2005084643A1 (en) * 2004-03-05 2005-09-15 H. Lundbeck A/S Crystalline composition containing escitalopram oxalate
US20050196453A1 (en) 2004-03-05 2005-09-08 H. Lundbeck A/S Crystalline composition containing escitalopram
ITMI20040717A1 (it) 2004-04-09 2004-07-09 Adorkem Technology Spa Procedimento chemo-enzimatico per la preparazione dell'escitalopram
JP2006008603A (ja) * 2004-06-25 2006-01-12 Sumitomo Chemical Co Ltd 光学活性シタロプラムの製造方法、その中間体およびその製造方法
US7989645B2 (en) * 2004-08-23 2011-08-02 Sun Pharma Global Fze Process for preparation of citalopram and enantiomers
DE05815687T1 (de) * 2004-08-23 2007-10-18 Sun Pharmaceutical Industries Ltd. Verfahren zur herstellung von citalopram und enantiomeren
EP1901714A2 (en) * 2005-05-20 2008-03-26 Aurobindo Pharma Limited Pharmaceutical dosage forms comprising escitalopram in form of granules
TWI347942B (en) * 2005-06-22 2011-09-01 Lundbeck & Co As H Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
JP2009511606A (ja) 2005-10-14 2009-03-19 ハー・ルンドベック・アクチエゼルスカベット エスシタロプラムおよびブプロピオンの低用量の併用を用いる中枢神経系障害の治療方法
WO2008059514A2 (en) * 2006-07-31 2008-05-22 Cadila Healthcare Limited Process for preparing escitalopram
US8022232B2 (en) 2007-09-11 2011-09-20 H. Lundbeck A/S Method for manufacture of escitalopram
NZ570884A (en) 2007-09-11 2010-03-26 Lundbeck & Co As H Fractionally crystallising 4-[4-(dimethyl amino)-1-(4'-fluorophenyl)-1-hydroxybutyI]-3-(hydroxymethyl)-benzonitrile and manufacturing escitalopram therefrom
CN100548974C (zh) * 2007-10-11 2009-10-14 浙江大学 西酞普兰中间体的萃取分离方法
CN101560199B (zh) * 2008-04-16 2013-09-18 北京德众万全药物技术开发有限公司 一种依地普仑的制备方法
TWI381813B (zh) 2010-01-12 2013-01-11 Taiwan Paiho Ltd A Velcro assembly for a foamed article and a foamed article comprising the adhesive tape assembly

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8419963D0 (en) * 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
TR200401456T1 (tr) * 1999-10-25 2005-04-21 H. Lundbeck A/S Sitalopram hazırlanması için yöntem.

Also Published As

Publication number Publication date
NO20035671L (no) 2003-12-18
HUP0400293A2 (hu) 2004-09-28
CA2691149A1 (en) 2003-01-03
CN100429208C (zh) 2008-10-29
CZ2004131A3 (cs) 2004-04-14
CN101440079B (zh) 2011-05-25
HK1132729A1 (en) 2010-03-05
HRP20031075B1 (en) 2011-12-31
CO5550420A2 (es) 2005-08-31
JP5064436B2 (ja) 2012-10-31
KR100939945B1 (ko) 2010-02-04
KR100902530B1 (ko) 2009-06-15
SK512004A3 (en) 2004-05-04
SI1412341T1 (en) 2005-04-30
ATE284395T1 (de) 2004-12-15
UY35850A (es) 2016-06-30
US7112686B2 (en) 2006-09-26
IL159229A0 (en) 2004-06-01
KR20100052550A (ko) 2010-05-19
HK1068627A1 (en) 2005-04-29
MY133471A (en) 2007-11-30
KR20090031958A (ko) 2009-03-30
JP2004536093A (ja) 2004-12-02
CN101440079A (zh) 2009-05-27
UY27356A1 (es) 2003-01-31
ES2233834T3 (es) 2005-06-16
CN1520405A (zh) 2004-08-11
EP1412341A1 (en) 2004-04-28
NO20035671D0 (no) 2003-12-18
BR0210574B1 (pt) 2014-03-04
MA26260A1 (fr) 2004-09-01
RS101403A (en) 2007-02-05
CA2450890A1 (en) 2003-01-03
CZ305034B6 (cs) 2015-04-08
HRP20031075A2 (en) 2004-04-30
HUP0400293A3 (en) 2007-05-29
UA75147C2 (en) 2006-03-15
IS2426B (is) 2008-10-15
AU2002344948B2 (en) 2007-08-16
RS50673B (sr) 2010-06-30
CA2450890C (en) 2011-02-15
TNSN02062A1 (en) 2005-12-23
DE60202216T2 (de) 2005-12-08
JP2009203233A (ja) 2009-09-10
US20040259940A1 (en) 2004-12-23
NO335106B1 (no) 2014-09-15
WO2003000672A1 (en) 2003-01-03
EA200400082A1 (ru) 2004-06-24
NO20101420L (no) 2003-12-18
NZ530104A (en) 2006-08-31
PT1412341E (pt) 2005-04-29
PE20030122A1 (es) 2003-02-12
HU228476B1 (en) 2013-03-28
BR0210574A (pt) 2004-08-03
MXPA03011770A (es) 2004-04-02
IS7068A (is) 2003-12-08
TWI236473B (en) 2005-07-21
KR20080100498A (ko) 2008-11-18
MEP1508A (xx) 2010-02-10
BG66372B1 (bg) 2013-10-31
DK1412341T3 (da) 2005-04-04
EA006446B1 (ru) 2005-12-29
AR083483A2 (es) 2013-02-27
AR034612A1 (es) 2004-03-03
SK287696B6 (sk) 2011-06-06
BRPI0210574B8 (pt) 2021-05-25
KR20040030702A (ko) 2004-04-09
EP1412341B1 (en) 2004-12-08
DE60202216D1 (de) 2005-01-13
JP4377219B2 (ja) 2009-12-02
PL366560A1 (en) 2005-02-07
ZA200309633B (en) 2005-02-23
CA2691149C (en) 2011-09-13
JO2389B1 (en) 2007-06-17
NO329873B1 (no) 2011-01-17
BG108532A (bg) 2005-04-30

Similar Documents

Publication Publication Date Title
ME00027B (me) Postupak pripremanja racemskog citaloprama i/ili s- ili r-citaloprama separacijom smješe r- i s-citaloprama
DK645689D0 (da) Nye piperazinderivater
SE0103046D0 (sv) Kristallin bas av citalopram
IE43506L (en) Isoquinolines
EA200200016A1 (ru) Способ получения чистого циталопрама
SU508192A3 (ru) Способ получени -(метоксиметил-фурилметил)-6,7-бензоморфанов или -морфинанов
JP2004536093A5 (ja) Ｒ−及びｓ−シタロプラムの混合物を分離することによってラセミシタロプラム及びｓ−もしくはｒ−シタロプラムを製造する方法
KR860009007A (ko) 피페리딜리덴 디하이드로-디벤조[a,d]-사이클로헵텐의 제조방법
US4520203A (en) Resolution of (±)-1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid using cinchonine
NO860830L (me)
ATE19394T1 (de) Verfahren zur herstellung von cyclopropancarbonsaeureesterderivaten.
IT1319195B1 (it) Processo per la produzione dell'acido r(+)alfa-lipoico.
US4515961A (en) Resolution of (±)-1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4,-b] indole-1-acetic acid using enrichment crystallization
DK552682A (da) Fremgangsmaade til fremstilling af hydroxybenzylaminobenzener
ES8100237A1 (es) Procedimiento para la separacion de los dos isomeros opticos del moprolol
UA84859C2 (ru) Способ получения свободной основы и/или кислотно-аддитивной соли рацемического циталопрамдиола и/или свободной основы и/или кислотно-аддитивной соли r- или s-циталопрамдиола
JPS60139679A (ja) ２−アリ−ルベンゾチアゾリン誘導体
DD240207A5 (de) Verfahren zur herstellung asymmetrischer hydantoine
CH685345A5 (it) Metodo per la preparazione di acido S-(+)-etodolico e di suoi derivati salini.
HRPK20070454B3 (en) A process for the preparation of racemic citalopram diol and/or s- or r- citalopram diols and the use of such diols for the preparation of racemic citalopram, r-citalopram and/or s-citalopram
DK123089A (da) Fremgangsmaade til adskillese af alpha-l-asparagyl-l-phenylalaninmethylester fra en oploesning
IE40218L (en) Process for recovering phenylalkylamines
DK1504021T3 (da) Fremgangsmåde til dehydrogenering af azaandrostanforbindelser
DE2822013A1 (de) Substituierte benzopyranverbindungen, deren herstellung und verwendung
GB1428938A (en) 2,5-dideoxystrptamines and 6,6-diaza-2,4-dihydroxy-bicyclo- 3,2,1-octanes and methods for their preparation